Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for inflammation in aortic valve replacement
NCT05641064Phase 3Completed
- Sponsor
- Dubrava University Hospital
- Start
- Nov 2022
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in Systemic Inflammatory Response Syndrome (SIRS), sponsored by Dubrava University Hospital. Started Nov 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on NCT05641064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05641064.